Menu
TVG has established a pipeline of animal vaccines that address infectious diseases in animals that are either zoonotic, transferred from animals to humans, or have a serious commercial impact on livestock production. We have an international network of collaborators and are funded by a number of sponsors, including the UK, Chinese and US governments.
Overview of TVG’s current in vitro R&D pipeline.
Internally funded.
Internally funded.
Funded by Innovate UK and Chinese government.
In collaboration with University of Liège and University of Plymouth
Funded by BactiVac
In collaboration with the Pirbright Institute.
Funded by ECO Animal Health.
Funded by Defra, ongoing work internally funded.
In collaboration with UC Davis, Heinrich Pette Institute, University of Western Australia, University of Idaho, University of Glasgow, University of Makeni and the National Institute of Allergy and Infectious Diseases.
Funded by DARPA.
In collaboration with UC Davis, Heinrich Pette Institute, University of Western Australia, University of Idaho, University of Glasgow, University of Makeni and the National Institute of Allergy and Infectious Diseases.
Funded by DARPA.